|
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for uterine cancer.
Updated January 2009
Printer friendly page
| Results 1 to 5 displayed. |
| Title: |
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Hormone therapy may be used to manage troublesome menopausal symptoms, but is currently recommended to be given at the lowest effective dose and regularly reviewed by a woman and her doctor. In women with an intact uterus hormone therapy comprising estr...
|
| Title: |
Adjuvant radiotherapy for stage I endometrial cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Women with stage I endometrial cancer have a low risk of recurrence of their disease. About 10% of women treated with surgery alone have a recurrence. This risk is significantly higher (and maybe double) for some women with high risk factors including g...
|
| Date: |
Feb 2007
|
| Title: |
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
These women have a poor prognosis. Giving extra drugs seems to reduce disease progression by a small amount. However, it does not seem to allow women to live longer. Also, more chemotherapy seems to cause a greater amount of serious short-term side effe...
|
| Date: |
Jun 2005
|
| Title: |
Progestagens for endometrial cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
No evidence to support use of adjuvant progestagens to prevent recurrence of endometrial cancer after surgery. Endometrial cancer is becoming the most common genital tract cancer in many western countries. Progestagen (a hormone) therapy is sometimes us...
|
| Date: |
Feb 2002
|
| Results 1 to 5 displayed. |
|